Mark Wilks

4.8k total citations · 1 hit paper
95 papers, 3.2k citations indexed

About

Mark Wilks is a scholar working on Epidemiology, Infectious Diseases and Molecular Biology. According to data from OpenAlex, Mark Wilks has authored 95 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 32 papers in Epidemiology, 25 papers in Infectious Diseases and 20 papers in Molecular Biology. Recurrent topics in Mark Wilks's work include Clostridium difficile and Clostridium perfringens research (15 papers), Antibiotic Resistance in Bacteria (12 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Mark Wilks is often cited by papers focused on Clostridium difficile and Clostridium perfringens research (15 papers), Antibiotic Resistance in Bacteria (12 papers) and Bacterial Identification and Susceptibility Testing (12 papers). Mark Wilks collaborates with scholars based in United Kingdom, Spain and France. Mark Wilks's co-authors include Michael Millar, S. Tabaqchali, Gavin C. Donaldson, Tom Wilkinson, Jadwiga A. Wedzicha, Irem Patel, Kate Costeloe, Pollyanna Hardy, Edmund Juszczak and Peter Mullany and has published in prestigious journals such as The Lancet, SHILAP Revista de lepidopterología and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Mark Wilks

91 papers receiving 3.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Bifidobacterium breve BBG-001 in very preterm infants: a randomised controlled phase 3 trial

2015 276 citations Kate Costeloe, Mark Wilks et al. profile →

Peers

Countries citing papers authored by Mark Wilks

Since Specialization

Citations

This map shows the geographic impact of Mark Wilks's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark Wilks with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark Wilks more than expected).

Fields of papers citing papers by Mark Wilks

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mark Wilks. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark Wilks. The network helps show where Mark Wilks may publish in the future.

Co-authorship network of co-authors of Mark Wilks

This figure shows the co-authorship network connecting the top 25 collaborators of Mark Wilks. A scholar is included among the top collaborators of Mark Wilks based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mark Wilks. Mark Wilks is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Bacterial DNA detection in blood using PCR/ESI-MS in neonates with suspected early onset infection 2025 ·Frontiers in Cellular and Infection Microbiology ·Ajay Sinha, Anja Saso, (unknown), Stephen Kempley, Mark Wilks, M. Millar	0
2	A point prevalence study to determine the inpatient rate of carbapenemase-producing organisms at a large London NHS Trust 2019 ·Journal of Hospital Infection ·Jennifer Henderson, Holly Ciesielczuk, (unknown), Mark Wilks, (unknown)	5
3	A service evaluation of simultaneous near-patient testing for influenza, respiratory syncytial virus, Clostridium difficile and norovirus in a UK district general hospital 2019 ·Journal of Hospital Infection ·(unknown), (unknown), Mark Wilks, Christine A. Welch, Mark Melzer	3
4	Toxigenic Clostridium difficile colonization among hospitalised adults; risk factors and impact on survival 2017 ·Journal of Infection ·(unknown), David Chadwick, Angela Dunne, Christopher I. Jones, (unknown), Chakravarthi Rajkumar, (unknown), Philip Stanley, Angela Whiley, Mark Wilks, Martin Llewelyn	12
5	ESBL-producing Enterobacteriaceae in 24 neonatal units and associated networks in the south of England: no clustering of ESBL-producingEscherichia coliin units or networks: Table 1. 2016 ·Journal of Antimicrobial Chemotherapy ·Michael Millar, (unknown), Jane F. Turton, Mark Wilks, Kate Costeloe, Neil Woodford, Ed Juszczak, Angela Whiley, (unknown), David W. Wareham	2
6	The detection of microbial DNA but not cultured bacteria is associated with increased mortality in patients with suspected sepsis—a prospective multi-centre European observational study 2016 ·Clinical Microbiology and Infection ·Michael J. O’Dwyer, (unknown), Jacques Schrenzel, Kai Zacharowski, David J. Ecker, Rangarajan Sampath, David Brealey, Mervyn Singer, Nicolas Libert, Mark Wilks, Jean‐Louis Vincent	24
7	Accuracy of bacterial DNA testing for central venous catheter-associated bloodstream infection in children with cancer 2011 ·Health Technology Assessment ·M. Millar, Weiwei Zhou, Roderick Skinner, Barry Pizer, Enid Hennessy, Mark Wilks, Ruth Gilbert	11
8	Bacteria and early human development 2007 ·Early Human Development ·Mark Wilks	30
9	Interaction of bacterial and rhinoviral infection during chronic obstructive pulmonary disease exacerbations 2006 ·UCL Discovery (University College London) ·Tom Wilkinson, (unknown), Wayomi R. Perera, Mark Wilks, (unknown), JA Wedzicha	1
10	Comparative study of diagnosis of PD peritonitis by quantitative polymerase chain reaction for bacterial DNA vs culture methods 2006 ·Journal of Nephrology ·Gemma Johnson, Mark Wilks, Simon Warwick, M. Millar, Stanley Fan	13
11	Detection of multiple-strain carriers: The value of re-sampling 2005 ·Journal of Theoretical Biology ·Pietro G. Coen, Mark Wilks, Martino Dall’Antonia, Michael Millar	7
12	Bronchiectasis, Exacerbation Indices, and Inflammation in Chronic Obstructive Pulmonary Disease 2004 ·American Journal of Respiratory and Critical Care Medicine ·Irem Patel, Ioannis Vlahos, Tom Wilkinson, (unknown), Gavin C. Donaldson, Mark Wilks, Rodney H. Reznek, Jadwiga A. Wedzicha	337
13	Airway Bacterial Load and FEV1 Decline in Patients with Chronic Obstructive Pulmonary Disease 2003 ·American Journal of Respiratory and Critical Care Medicine ·Tom Wilkinson, Irem Patel, Mark Wilks, Gavin C. Donaldson, Jadwiga A. Wedzicha	284
14	Expression of Helicobacter pylori urease subunit B gene in Lactococcus lactis MG1363 and its use as a vaccine delivery system against H. pylori infection in mice 2001 ·Vaccine ·(unknown), Yvonne Roussel, Mark Wilks, S. Tabaqchali	82
15	A group II intron in a conjugative transposon from the gram-positive bacterium, Clostridium difficile 1996 ·Gene ·Peter Mullany, Mark J. Pallen, Mark Wilks, J. Stephen, S. Tabaqchali	62
16	Typing of Clostridium difficile by polymerase chain reaction with an arbitrary primer 1994 ·Journal of Hospital Infection ·Mark Wilks, S. Tabaqchali	14
17	Mycobacterium paratuberculosis and Crohn's disease. 1991 ·Gut ·(unknown), Mark Wilks, Philip J. Coates, M.J.G. Farthing, J A Walker‐Smith, S. Tabaqchali	52
18	A double-blind comparison of the effects of cefaclor and amoxycillin on respiratory tract and oropharyngeal flora and clinical response in acute exacerbations of bronchitis 1991 ·Respiratory Medicine ·C.J. Trigg, Mark Wilks, Michael Herdman, J.E. Clague, S. Tabaqchali, R. Jeremy H. Davies	8
19	Gastrointestinal Blood Loss in Haemodialysis Patients During Use of a Low-molecular-weight Heparinoid Anticoagulant 1988 ·Nephrology Dialysis Transplantation ·Ulrich Frei, Mark Wilks, Susan Boehmer, (unknown), (unknown), (unknown), (unknown)	12
20	Quantitative bacteriology of the vaginal flora during the menstrual cycle 1987 ·Journal of Medical Microbiology ·Mark Wilks, S. Tabaqchali	27

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact